Aurora Cannabis Receives Australian Stamp of Approval

Global medical cannabis company, Aurora Cannabis (Nasdaq: ACB) has received a landmark certification from Australian authorities for cannabis products from its Canadian production facilities. The company announced on Wednesday that it has secured Good Manufacturing Practice (GMP) certification from Australia’s Therapeutic Goods Administration (TGA) for its Canadian production facilities, River and Ridge. The company’s share price rose nearly 5% in intraday trading following the news.

The certification enables Aurora to deliver top-tier cannabis products to Australia, including dried flower, resin cartridges, pastilles and oils.

Commenting on the news, Gorana Lakic, Vice President, Quality at Aurora, said, “I’m proud to announce Aurora has obtained TGA GMP certification for our world class Canadian production facilities. This achievement adds to the number of global certifications Aurora has received and solidifies our dedication to quality and compliance. With this significant achievement, we reaffirm our commitment to maintaining the highest standards and manufacturing practices to deliver premium medical cannabis products to our valued patients.” 

Highlights

The Australian medical cannabis market is estimated to be worth $400 million AUD, and is rapidly expanding, making it the largest medical market in the world outside of North America.

Aurora is an exclusive supplier to MedReleaf Australia.

The TGA is responsible for regulating the supply, import, export, manufacturing and advertising of therapeutic goods in Australia.  

About Aurora Cannabis

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult- use brand portfolio includes Drift, San Rafael ’71, Daily Special, Tasty’s, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America’s leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn.

Share This Article

 

About the Author

Aurora Cannabis Receives Australian Stamp of Approval

Editor Prism MarketView